is fda stopping semaglutide Declares Shortage of Novo Nordisk's Wegovy, Ozempic Over The End of Compounded Semaglutide?

Based on the STEP 1 clinical study, the semaglutide-treated group reported weight loss beginning with the first assessment after randomization at week 4, reaching its lowest reported weight loss at week 60.[2,4] STEP 1 included 1961 patients randomly assigned to treatment with semaglutide or placebo combined with diet and exercise.[4] Dosage Forms And Strengths Semaglutide is currently available as a clear and colorless injectable solution.[2] The injections come in five different pre-filled, disposable, and single-dose pens[2]: 0.25 mg/0.5 mL 0.5 mg/0.5 mL 1 mg/0.5 mL 1.7 mg/0.5 mL 2.4 mg/0.5 mL Safety Common side effects of semaglutide are gastrointestinal-related.[2,5] These are nausea, vomiting, and diarrhea

Brain Activity fMRI scans reveal heightened activity in reward centers (e.g., striatum) and reduced activity in impulse-control regions (e.g., prefrontal cortex) in those with obesity, creating a double whammy for food noise

It depends on whether youre taking oral or injectable semaglutide

In a recent HealthCentral article, Elizabeth Wassenaar, MS, MD, DFAPA, CEDS-S provides expert insight into the mental health impact of GLP-1A medications

Ozempic works by regulating blood sugar and controlling appetite, so combining it with a balanced, healthy diet is essential for optimal results

It could exacerbate the condition or lead to adverse effects, just as it may interact negatively with other drugs